See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
NASDAQ:CERU
Delisted

Cerulean Pharma Fund Predictions

etoro logo Buy CERU
*Your capital is at risk
$0.660
+0 (+0%)
At Close: Jan 16, 2018
Forecast Signals Historical Prices Predictions News Profile
Currently predicting for Fri, 5 Jun 2026

CERU Prediction Chart

CERU Predictions History

Latest community submissions for CERU.
Predictor Target Session Target Price Result Direction Accuracy Score
Jake Jake @Jake.10713
Aug 14, 2017 $1.23 +87.50% $0.660 V 12.50% 0
JS JS Pro
Jul 17, 2017 $0.693 +6.62% $0.650 X 93.40% 0
bbullish2 bbullish2 Merchant @bbullish2.7792
Jul 17, 2017 $0.660 +1.54% $0.650 X 98.50% 0
JS JS Pro
Jul 10, 2017 $0.709 -12.93% $0.81 V 87.10% 0
JuanC Villegas JuanC Villegas Pro
Jul 10, 2017 $0.682 -16.25% $0.81 V 83.80% 0
JS JS Pro
Jul 6, 2017 $1.01 +26.25% $0.80 X 73.80% 0
Bobbin.on.cocks.4.stocks.9195 Bobbin.on.cocks.4.stocks.9195
Jul 6, 2017 $0.0100 -98.75% $0.80 X 1.20% 0
Salty.Hairy.Coco.Boobies.9193 Salty.Hairy.Coco.Boobies.9193
Jul 6, 2017 $0.110 -86.25% $0.80 X 13.70% 0
Laurie.s.hair.9190 Laurie.s.hair.9190
Jul 6, 2017 $0.0800 -90.00% $0.80 X 10.00% 0
Jenny.j.9181 Jenny.j.9181
Jul 6, 2017 $0.289 -63.88% $0.80 X 36.10% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CERU with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
Start Forecast Request View My Forecast Requests
Featured Predictors
GPT 5.4 Reply target 48h
Select
Gemini 3.5 Reply target 48h
Select
Opus 4.7 Reply target 48h
Select
ABOUT CERULEAN PHARMA INC.
Cerulean Pharma Inc., a clinical-stage company, develops nanotechnology-based therapeutics in the areas of oncology and other diseases in the United States. The company’s lead product candidate is CRLX101, a tumor targeted nanoparticle-drug conjugate (NDC), which is in Phase 2 clinical development in patients with renal cell carcinoma; and in Phase 2 and Phase 1b clinical development in patients with ovarian cancer. It is also developing CRLX301...
Read Full Profile Here
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE